These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 36180702)
1. Measurement of NQO2 Catalytic Activity and of Its Inhibition by Melatonin. Ferry G; Boutin JA Methods Mol Biol; 2022; 2550():315-321. PubMed ID: 36180702 [TBL] [Abstract][Full Text] [Related]
2. Organs from mice deleted for NRH:quinone oxidoreductase 2 are deprived of the melatonin binding site MT3. Mailliet F; Ferry G; Vella F; Thiam K; Delagrange P; Boutin JA FEBS Lett; 2004 Dec; 578(1-2):116-20. PubMed ID: 15581627 [TBL] [Abstract][Full Text] [Related]
3. Measuring Binding at the Putative Melatonin Receptor MT3. Legros C; Dupuis P; Ferry G; Boutin JA Methods Mol Biol; 2022; 2550():283-289. PubMed ID: 36180699 [TBL] [Abstract][Full Text] [Related]
4. Cloning, Expression, Purification, Crystallization, and X-Ray Structural Determination of the Human NQO2 in Complex with Melatonin. Calamini B; Ferry G; Boutin JA Methods Mol Biol; 2022; 2550():291-304. PubMed ID: 36180700 [TBL] [Abstract][Full Text] [Related]
5. Measuring the NQO2: Melatonin Complex by Native Nano-Electrospray Ionization Mass Spectrometry. Boutin JA; Stojko J; Ferry G; Cianferani S Methods Mol Biol; 2022; 2550():323-328. PubMed ID: 36180703 [TBL] [Abstract][Full Text] [Related]
6. MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate. Boutin JA; Marcheteau E; Hennig P; Moulharat N; Berger S; Delagrange P; Bouchet JP; Ferry G J Pineal Res; 2008 Nov; 45(4):524-31. PubMed ID: 18826489 [TBL] [Abstract][Full Text] [Related]
7. Melatonin Binding to Human NQO2 by Isothermal Titration Calorimetry. Calamini B; Ferry G; Boutin JA Methods Mol Biol; 2022; 2550():305-314. PubMed ID: 36180701 [TBL] [Abstract][Full Text] [Related]
8. Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones. Gaikwad NW; Yang L; Rogan EG; Cavalieri EL Free Radic Biol Med; 2009 Jan; 46(2):253-62. PubMed ID: 18996184 [TBL] [Abstract][Full Text] [Related]
9. Is There Sufficient Evidence that the Melatonin Binding Site Boutin JA; Ferry G J Pharmacol Exp Ther; 2019 Jan; 368(1):59-65. PubMed ID: 30389722 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the melatoninergic MT3 binding site on the NRH:quinone oxidoreductase 2 enzyme. Mailliet F; Ferry G; Vella F; Berger S; Cogé F; Chomarat P; Mallet C; Guénin SP; Guillaumet G; Viaud-Massuard MC; Yous S; Delagrange P; Boutin JA Biochem Pharmacol; 2005 Dec; 71(1-2):74-88. PubMed ID: 16293234 [TBL] [Abstract][Full Text] [Related]
11. Studies of the melatonin binding site location onto quinone reductase 2 by directed mutagenesis. Boutin JA; Saunier C; Guenin SP; Berger S; Moulharat N; Gohier A; Delagrange P; Cogé F; Ferry G Arch Biochem Biophys; 2008 Sep; 477(1):12-9. PubMed ID: 18502195 [TBL] [Abstract][Full Text] [Related]
12. NQO2 inhibition relieves reactive oxygen species effects on mouse oocyte meiotic maturation and embryo development. Chen D; Li X; Liu X; Liu X; Jiang X; Du J; Wang Q; Liang Y; Ma W Biol Reprod; 2017 Oct; 97(4):598-611. PubMed ID: 29025057 [TBL] [Abstract][Full Text] [Related]
13. New ligands at the melatonin binding site MT(3). Boussard MF; Truche S; Rousseau-Rojas A; Briss S; Descamps S; Droual M; Wierzbicki M; Ferry G; Audinot V; Delagrange P; Boutin JA Eur J Med Chem; 2006 Mar; 41(3):306-20. PubMed ID: 16414149 [TBL] [Abstract][Full Text] [Related]
14. MT3 melatonin binding site, MT1 and MT2 melatonin receptors are present in oocyte, but only MT1 is present in bovine blastocyst produced in vitro. Sampaio RV; Conceição S; Miranda MS; Sampaio Lde F; Ohashi OM Reprod Biol Endocrinol; 2012 Dec; 10():103. PubMed ID: 23207065 [TBL] [Abstract][Full Text] [Related]
15. 5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit. Alarma-Estrany P; Crooke A; Pintor J J Pineal Res; 2009 Sep; 47(2):201-209. PubMed ID: 19627460 [TBL] [Abstract][Full Text] [Related]
17. Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems. Yan C; Dufour M; Siegel D; Reigan P; Gomez J; Shieh B; Moody CJ; Ross D Biochemistry; 2011 Aug; 50(31):6678-88. PubMed ID: 21718050 [TBL] [Abstract][Full Text] [Related]
18. Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Fischer TW; Zmijewski MA; Zbytek B; Sweatman TW; Slominski RM; Wortsman J; Slominski A Int J Oncol; 2006 Sep; 29(3):665-72. PubMed ID: 16865283 [TBL] [Abstract][Full Text] [Related]
19. NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP-C4-2B prostate cancer model of progressive metastasis. Dorai T; Shah A; Summers F; Mathew R; Huang J; Hsieh TC; Wu JM Prostate; 2018 Nov; 78(15):1181-1195. PubMed ID: 30009389 [TBL] [Abstract][Full Text] [Related]
20. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT. Leung KK; Shilton BH Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]